🇺🇸 Methotrexate/Hydrocortisone in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hypertension — 2 reports (18.18%)
  2. Abdominal Compartment Syndrome — 1 report (9.09%)
  3. Drug Tolerance Decreased — 1 report (9.09%)
  4. Febrile Neutropenia — 1 report (9.09%)
  5. Fungal Infection — 1 report (9.09%)
  6. Hepatic Failure — 1 report (9.09%)
  7. Mental Status Changes — 1 report (9.09%)
  8. Pancytopenia — 1 report (9.09%)
  9. Renal Failure — 1 report (9.09%)
  10. Sepsis — 1 report (9.09%)

Source database →

Other Oncology, Immunology approved in United States

Frequently asked questions

Is Methotrexate/Hydrocortisone approved in United States?

Methotrexate/Hydrocortisone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Methotrexate/Hydrocortisone in United States?

Dana-Farber Cancer Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.